This HTML5 document contains 150 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-dahttp://da.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n8https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n26http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
n5https://web.archive.org/web/20160817133724/http:/ir.alk-abello.com/
n21http://ir.alk-abello.com/
n14http://
n15http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
dbpedia-arhttp://ar.dbpedia.org/resource/
owlhttp://www.w3.org/2002/07/owl#
dbpedia-frhttp://fr.dbpedia.org/resource/
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
dbchttp://dbpedia.org/resource/Category:
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:ALK-Abelló
rdf:type
dbo:Organisation yago:Institution108053576 yago:WikicatPharmaceuticalCompaniesOfDenmark yago:Abstraction100002137 yago:WikicatBiotechnologyCompaniesOfDenmark yago:Group100031264 yago:WikicatLifeScienceCompaniesBasedInCopenhagen yago:WikicatCompaniesListedOnTheOMXExchanges owl:Thing wikidata:Q24229398 yago:SocialGroup107950920 yago:Organization108008335 yago:Company108058098 dbo:Company yago:DrugCompany108002578 schema:Organization yago:YagoLegalActor yago:YagoLegalActorGeo wikidata:Q43229 dbo:Agent yago:YagoPermanentlyLocatedEntity wikidata:Q4830453 n26:Agent n26:SocialPerson
rdfs:label
ALK-Abelló ALK-أبيلو ALK-Abelló
rdfs:comment
ALK-Abelló (OMX : ALK B), plus communément appelé ALK, est un groupe pharmaceutique dont le siège est au Danemark. Ce laboratoire est spécialisé dans le développement et la production de produits d’immunothérapie allergénique (ITA) pour la prévention et le traitement d’allergies. Il s’agit du premier producteur mondial de produits d’immunothérapie allergénique (ou produits de désensibilisation) avec 76 % de son chiffre d’affaires réalisé en Europe. ALK-Abelló A/S (Nasdaq Copenhagen: ALK B), also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergy. It is one of the world’s largest makers of allergy immunotherapy products (also known as ‘allergy vaccines’) with 81% of its revenue coming from sales in Europe. ALK-أبيلو المعروفة أيضًا باسم ALK، هي شركة أدوية مقرها الدنمارك متخصصة في تطوير وتصنيع منتجات العلاج المناعي للحساسية (AIT) للوقاية من الحساسية وعلاجها. وهي واحدة من أكبر الشركات المصنعة في العالم لمنتجات العلاج المناعي للحساسية (تُعرف أيضًا باسم "لقاحات الحساسية") حيث يأتي 81٪ من إيراداتها من المبيعات في أوروبا.
foaf:name
ALK-Abelló A/S
foaf:homepage
n14:www.alk.net
dbp:name
ALK-Abelló A/S
foaf:depiction
n15:ALK-Abelló_logo.svg
dbo:location
dbr:Hørsholm
dcterms:subject
dbc:Companies_listed_on_Nasdaq_Copenhagen dbc:Life_science_companies_based_in_Copenhagen dbc:Pharmaceutical_companies_established_in_1923 dbc:Biotechnology_companies_of_Denmark dbc:Pharmaceutical_companies_of_Denmark dbc:Companies_based_in_Rudersdal_Municipality dbc:Danish_companies_established_in_1923
dbo:wikiPageID
6789892
dbo:wikiPageRevisionID
1105281694
dbo:wikiPageWikiLink
dbr:Steen_Riisgaard dbr:Exclusive_rights dbr:Copenhagen dbr:House_dust_mite_allergy dbr:Vendeuil dbr:Oklahoma dbr:Sublingual_immunotherapy dbr:Schering-Plough dbr:House_dust_mite dbr:Allergy_immunotherapy dbr:Rigshospitalet dbr:Skin_prick_tests dbr:Port_Washington,_New_York dbr:Copenhagen_University_Hospital dbr:Aktieselskab dbr:Chair_(official) dbr:Ontario dbr:Mississauga dbr:Excipient dbr:Collaboration dbr:Idaho dbr:Abbott_Laboratories dbr:Research_and_Development dbr:Pharmaceutical dbr:World_Allergy_Organization dbr:Copenhagen_Stock_Exchange dbr:Chief_Executive_Officer dbr:Merck_&_Co dbr:Hørsholm dbr:New_York_(state) dbr:Pharmaceutical_company dbr:Madrid dbr:Danish_krone dbr:Ragweed dbr:Anaphylaxis dbc:Companies_listed_on_Nasdaq_Copenhagen dbc:Life_science_companies_based_in_Copenhagen dbc:Biotechnology_companies_of_Denmark dbr:European_Academy_of_Allergy_and_Clinical_Immunology dbr:Strategic_alliance dbr:Employee_elected dbc:Pharmaceutical_companies_established_in_1923 dbr:Japanese_cedar dbr:President_(corporate_title) dbr:Executive_Vice_President dbc:Pharmaceutical_companies_of_Denmark dbr:Audit_committee dbr:Post_Falls dbr:Australia dbr:Allergen dbr:Symposium_on_Specific_Allergy dbc:Danish_companies_established_in_1923 dbr:Oklahoma_City dbr:New_Zealand dbr:Capital_Region_of_Denmark dbr:Varennes-en-Argonne dbr:Merck_&_Co. dbc:Companies_based_in_Rudersdal_Municipality dbr:Lundbeck dbr:Chairman_of_the_board dbr:Milan dbr:Chief_Financial_Officer dbr:Allergy dbr:Subcutaneous_immunotherapy dbr:Eddingpharm dbr:Epinephrine_autoinjector
dbo:wikiPageExternalLink
n5:releasedetail.cfm%3FReleaseID=981222%7Carchive-date=2016-08-17%7Curl-status=dead n21:releasedetail.cfm%3FReleaseID=981222%7Ctitle=All n14:www.alk.net
owl:sameAs
n8:4KT4y dbpedia-da:ALK-Abelló dbpedia-ar:ALK-أبيلو wikidata:Q4652383 dbpedia-fr:ALK-Abelló freebase:m.0gp1d3
dbp:wikiPageUsesTemplate
dbt:OMX dbt:Profit dbt:Infobox_company dbt:Cite_web dbt:Reflist
dbo:thumbnail
n15:ALK-Abelló_logo.svg?width=300
dbp:foundation
1923
dbp:homepage
n14:www.alk.net
dbp:industry
Pharmaceuticals
dbp:keyPeople
Carsten Hellmann (CEO) Steen Riisgaard (Chairman)
dbp:location
Hørsholm, Denmark
dbp:logo
ALK-Abelló logo.svg
dbp:numEmployees
2300
dbp:products
Acarizax, Grazax, SlitOneUltra, Alutard SQ, Jext
dbp:revenue
DKK 3,005 million
dbp:type
dbr:Aktieselskab
dbo:abstract
ALK-Abelló A/S (Nasdaq Copenhagen: ALK B), also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergy. It is one of the world’s largest makers of allergy immunotherapy products (also known as ‘allergy vaccines’) with 81% of its revenue coming from sales in Europe. ALK-أبيلو المعروفة أيضًا باسم ALK، هي شركة أدوية مقرها الدنمارك متخصصة في تطوير وتصنيع منتجات العلاج المناعي للحساسية (AIT) للوقاية من الحساسية وعلاجها. وهي واحدة من أكبر الشركات المصنعة في العالم لمنتجات العلاج المناعي للحساسية (تُعرف أيضًا باسم "لقاحات الحساسية") حيث يأتي 81٪ من إيراداتها من المبيعات في أوروبا. ALK-Abelló (OMX : ALK B), plus communément appelé ALK, est un groupe pharmaceutique dont le siège est au Danemark. Ce laboratoire est spécialisé dans le développement et la production de produits d’immunothérapie allergénique (ITA) pour la prévention et le traitement d’allergies. Il s’agit du premier producteur mondial de produits d’immunothérapie allergénique (ou produits de désensibilisation) avec 76 % de son chiffre d’affaires réalisé en Europe.
gold:hypernym
dbr:Company
prov:wasDerivedFrom
wikipedia-en:ALK-Abelló?oldid=1105281694&ns=0
dbo:wikiPageLength
20074
dbo:foundingYear
1923-01-01
dbo:numberOfEmployees
2300
dbo:revenue
3005.0
dbo:industry
dbr:Pharmaceutical
dbo:keyPerson
dbr:Steen_Riisgaard dbr:Chief_Executive_Officer
dbo:type
dbr:Aktieselskab
foaf:isPrimaryTopicOf
wikipedia-en:ALK-Abelló